LON:BIOG The Biotech Growth Trust Interim Earnings Report GBX 1,262 +22.00 (+1.77%) As of 06/11/2026 12:00 PM Eastern ProfileEarnings History The Biotech Growth Trust EPS ResultsActual EPS-GBX 1Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AThe Biotech Growth Trust Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AThe Biotech Growth Trust Announcement DetailsQuarterInterimDate11/20/2025TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile The Biotech Growth Trust Earnings HeadlinesThe Biotech Growth Trust PLC - GSK plc to acquire BIOG portfolio company, Nuvalent, Inc.June 9 at 9:44 AM | uk.finance.yahoo.comThe Biotech Growth Trust PLC - Annual Financial ReportJune 4, 2026 | uk.finance.yahoo.comRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change. | Porter & Company (Ad)The Biotech Growth Trust (LON:BIOG) Stock Price Passes Below 50 Day Moving Average - Here's What HappenedJune 3, 2026 | americanbankingnews.comThe Biotech Growth Trust PLC - Monthly Fact Sheet as at 30 April 2026May 14, 2026 | uk.finance.yahoo.comThe Biotech Growth Trust PLC - ARCHIMED to acquire BIOG portfolio company, Esperion Therapeutics.May 1, 2026 | uk.finance.yahoo.comSee More The Biotech Growth Trust Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like The Biotech Growth Trust? Sign up for Earnings360's daily newsletter to receive timely earnings updates on The Biotech Growth Trust and other key companies, straight to your email. Email Address About The Biotech Growth TrustThe Biotech Growth Trust (LON:BIOG) seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).View The Biotech Growth Trust ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Spotify's "North Star" Outlook Was Music to Investors EarsCracker Barrel Surges 23% as Earnings Beat Signals Turnaround ProgressChewy’s Growth Engine Is Stronger Than the Market ThinksCasey’s Is Looking Like a Hot Buy as Growth, Buybacks, and Guidance AlignThe “Duck Stock” Keeps Quietly Making Money for ShareholdersEverpure: AI Storage Uncertainty Overshadows Breakneck GrowthAs Shares Fall, Analyst Are Boosting their Broadcom Price Targets Upcoming Earnings Accenture (6/18/2026)FedEx (6/23/2026)Micron Technology (6/24/2026)NIKE (6/30/2026)PepsiCo (7/9/2026)Delta Air Lines (7/9/2026)Fastenal (7/13/2026)Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026)JPMorgan Chase & Co. (7/14/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
